Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center, University of Rochester (N.Y.) Wilmot Cancer Institute and New York City-based Mount Sinai, NYU Langone Health and Weill Cornell Medicine have established the Empire State Cellular Therapy Consortium.
Member organizations will have expanded access to resources across the consortium, including Roswell Park’s $98 million GMP Engineering & Cell Manufacturing Facility, according to a July 10 news release from the cancer center.
“Consortium members expect to open several clinical trials within the next two years,” the release said. “[Members] will also collaborate to expand patients’ access to standard-of-care cell therapies already approved by the FDA.”
The consortium officially launched in February with Marco Davila, MD, PhD, senior vice president and associate director of translational research at Roswell Park, serving as the consortium’s inaugural chair.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
